Dafna Capital Management LLC: holdings and changes
Number 51 of the top 100 funds by copy return. Dafna Capital Management LLC reported 87 US stocks worth $468M for the quarter ending 2026-09-30 and changed 4 new, 15 added, 24 trimmed and 5 sold since 2026-06-30.
Copy return, 4 quarters+46.1%
US 500, same time+14.5%
Size$468M
Stocks87
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| RVMD Revolution Medicines INC | TRIM -13% | 21.36% | $100M | 487,130 |
| ATRC Atricure INC | TRIM -13% | 6.28% | $29M | 522,747 |
| CMPS Compass Pathways PLC | ADD +6% | 5.68% | $27M | 2,135,952 |
| SPDR SERIES TR Spdr Series Trust | TRIM -23% | 5.10% | $24M | 151,505 |
| NKTR Nektar Therapeutics | 4.18% | $20M | 323,380 | |
| IDYA Ideaya Biosciences INC | TRIM -12% | 3.60% | $17M | 438,740 |
| STXS Stereotaxis INC | 3.60% | $17M | 13,680,554 | |
| DNLI Denali Therapeutics INC | 3.29% | $15M | 744,014 | |
| ASND Ascendis Pharma A/S | ADD +3% | 2.43% | $11M | 49,969 |
| RCUS Arcus Biosciences INC | 2.43% | $11M | 439,829 | |
| CYTK Cytokinetics INC. | 2.42% | $11M | 171,998 | |
| EWTX Edgewise Therapeutics INC | 1.92% | $9M | 221,819 | |
| NBIX Neurocrine Biosciences INC | ADD +9% | 1.90% | $9M | 62,716 |
| PODD Insulet Corp | ADD +10% | 1.89% | $9M | 67,870 |
| XENE Xenon Pharmaceuticals INC | TRIM -18% | 1.63% | $8M | 204,772 |
| AXGN Axogen INC | TRIM -14% | 1.61% | $8M | 179,960 |
| DXCM Dexcom INC | 1.59% | $7M | 86,279 | |
| SNDX Syndax Pharmaceuticals INC | 1.33% | $6M | 331,290 | |
| LRMR Larimar Therapeutics INC | TRIM -6% | 1.29% | $6M | 1,888,155 |
| TNDM Tandem Diabetes Care INC | 1.24% | $6M | 355,208 | |
| BCAX Bicara Thera INC | ADD +5% | 1.19% | $6M | 299,955 |
| RAPP Rapport Therapeutics INC | ADD +89% | 1.02% | $5M | 141,900 |
| IMVT Immunovant INC | TRIM -9% | 0.98% | $5M | 135,524 |
| INGN Inogen INC | 0.95% | $4M | 845,179 | |
| NGNE Neurogene INC Com | ADD +69% | 0.89% | $4M | 150,532 |
| ALKS Alkermes PLC | 0.88% | $4M | 101,266 | |
| IPSC Century Therapeutics INC | 0.87% | $4M | 2,386,750 | |
| KIDS Orthopediatrics Corp | TRIM -5% | 0.85% | $4M | 179,130 |
| GALAPAGOS NV Galapagos Nv | 0.82% | $4M | 130,175 | |
| STOK Stoke Therapeutics INC | ADD +12% | 0.81% | $4M | 146,135 |
| ANL Adlai Nortye LTD | 0.80% | $4M | 232,763 | |
| EPRX Eupraxia Pharmaceuticals INC | ADD +79% | 0.79% | $4M | 404,567 |
| CLDX Celldex Therapeutics INC | ADD +58% | 0.75% | $4M | 108,118 |
| ALLO Allogene Therapeutics INC | 0.68% | $3M | 2,000,000 | |
| BCRX Biocryst Pharmaceuticals INC | TRIM -5% | 0.68% | $3M | 380,248 |
| KYMR Kymera Therapeutics INC | 0.64% | $3M | 26,912 | |
| AQST Aquestive Therapeutics INC | 0.63% | $3M | 640,915 | |
| RNA Atrium Therapeutics INC | ADD +134% | 0.53% | $2M | 300,076 |
| iShares Nasdaq Ishares Nasdaq Biotechnology | TRIM -73% | 0.52% | $2M | 11,595 |
| PRCT Procept Biorobotics Corp | 0.47% | $2M | 120,000 | |
| PROQR THRAPEUT Proqr Thrapeutics N V | TRIM -14% | 0.47% | $2M | 1,312,530 |
| CYBIN INC Cybin INC | TRIM -66% | 0.46% | $2M | 175,702 |
| ALGN Align Technology INC Com | 0.43% | $2M | 14,000 | |
| VKTX Viking Therapeutics INC | TRIM -8% | 0.38% | $2M | 54,516 |
| MAZE Maze Therapeutics | 0.38% | $2M | 65,000 | |
| ALEC Alector INC Com | 0.36% | $2M | 908,351 | |
| TELA Tela Bio INC | 0.35% | $2M | 1,441,029 | |
| MPLT Maplight Therapeutics INC | TRIM -9% | 0.34% | $2M | 155,579 |
| NGEN Nervgen Pharma Ord | TRIM -23% | 0.33% | $2M | 810,862 |
| GPCR Structure Therapeutics INC | 0.31% | $2M | 46,500 | |
| PROF Profound Med Corp | TRIM -14% | 0.28% | $1M | 225,094 |
| MDWD Mediwound LTD | 0.28% | $1M | 94,405 | |
| DSGN Design Therapeutics INC | 0.27% | $1M | 102,100 | |
| LXEO Lexeo Therapeutics INC | 0.27% | $1M | 377,059 | |
| INSP Inspire Med Sys INC | 0.27% | $1M | 18,200 | |
| CTMX Cytomx Therapeutics INC | 0.25% | $1M | 438,407 | |
| FATE Fate Therapeutics INC | TRIM -5% | 0.25% | $1M | 500,000 |
| MLYS Mineralys Therapeutics INC | 0.24% | $1M | 44,490 | |
| PYPD Polypid LTD | 0.23% | $1M | 207,900 | |
| BBOT Bridgebio Oncology Therapeutics Ord | BUY | 0.23% | $1M | 266,038 |
| ANNX Annexon INC | TRIM -13% | 0.23% | $1M | 257,637 |
| BHVN Biohaven LTD | TRIM -44% | 0.22% | $1M | 77,593 |
| IMTX Immatics N.V | 0.22% | $1M | 116,960 | |
| QTTB Q32 Bio INC. | ADD +199% | 0.17% | $800k | 98,500 |
| PYXS Pyxis Oncology INC | BUY | 0.17% | $800k | 344,820 |
| SILVERBACK THE Silverback Therapeutics INC | ADD +11% | 0.17% | $800k | 182,785 |
| RARE Ultragenyx Pharmaceutical In | ADD +8% | 0.16% | $800k | 51,100 |
| KURA Kura Oncology INC | TRIM -43% | 0.16% | $700k | 69,068 |
| BNTX Biontech Se | 0.15% | $700k | 7,000 | |
| SCYX Scynexis INC | 0.14% | $700k | 135,868 | |
| ACET Adicet Bio INC | 0.14% | $700k | 93,812 | |
| SPTX Seaport Therapeutics INC | 0.14% | $700k | 32,400 | |
| QNRX Quoin Pharmaceuticals LTD Adr | BUY | 0.13% | $600k | 132,156 |
| CRBP Corbus Pharmaceuticals Hldgs | TRIM -23% | 0.12% | $600k | 83,248 |
| PLRX Pliant Therapeutics INC | 0.11% | $500k | 487,000 | |
| EDIT Editas Medicine INC | ADD +6% | 0.10% | $500k | 180,470 |
| ARAY Accuray INC | 0.10% | $500k | 1,680,508 | |
| CGEN *compugen LTD | 0.09% | $400k | 168,232 | |
| AUTL Autolus Therapeu | 0.07% | $300k | 179,316 | |
| FHTX Foghorn Therapeutics INC | TRIM -20% | 0.07% | $300k | 89,659 |
| ARTV Artiva Biotherapeutics INC | SELL | 0% | was $700k | 0 |
| MBX Mbx Biosciences INC | SELL | 0% | was $700k | 0 |
| OBIO Orchestra Biomed Hldgs INC | SELL | 0% | was $500k | 0 |
| NVCT Nuvectis Pharma INC | SELL | 0% | was $400k | 0 |
| BCYC Bicycle Therapeutics PLC | SELL | 0% | was $300k | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2023-09-30 → 2023-12-31 | +34.2% | +11.2% |
| 2023-12-31 → 2024-03-31 | +15.8% | +10.0% |
| 2024-03-31 → 2024-06-30 | -11.3% | +4.0% |
| 2024-06-30 → 2024-09-30 | +6.1% | +5.4% |
| 2024-09-30 → 2024-12-31 | -12.0% | +2.1% |
| 2024-12-31 → 2025-03-31 | -13.5% | -4.6% |
| 2025-03-31 → 2025-06-30 | +6.2% | +10.5% |
| 2025-06-30 → 2025-09-30 | +33.0% | +7.8% |
| 2025-09-30 → 2025-12-31 | +16.3% | +2.4% |
| 2025-12-31 → 2026-03-31 | +2.6% | -4.6% |
| 2026-03-31 → 2026-06-30 | +27.2% | +14.8% |
| 2026-06-30 → 2026-09-30 | -3.7% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP